Institution
Charlie Norwood VA Medical Center
Healthcare•Augusta, Georgia, United States•
About: Charlie Norwood VA Medical Center is a healthcare organization based out in Augusta, Georgia, United States. It is known for research contribution in the topics: Autophagy & Kidney. The organization has 349 authors who have published 490 publications receiving 16360 citations. The organization is also known as: Augusta VA Medical Center.
Topics: Autophagy, Kidney, Acute kidney injury, Cancer, Prostate cancer
Papers
More filters
01 Dec 2019
TL;DR: In this paper, the authors demonstrate an important role of macroautophagy and autophagy regulator PINK1 (PTEN induced putative kinase 1) was activated during IPC and BECN1 peptide enhanced mitolysosome formation during renal IRI.
Abstract: Ischemic preconditioning (IPC) affords tissue protection in organs including kidneys; however, the underlying mechanism remains unclear. Here we demonstrate an important role of macroautophagy/autophagy (especially mitophagy) in the protective effect of IPC in kidneys. IPC induced autophagy in renal tubular cells in mice and suppressed subsequent renal ischemia-reperfusion injury (IRI). The protective effect of IPC was abolished by pharmacological inhibitors of autophagy and by the ablation of Atg7 from kidney proximal tubules. Pretreatment with BECN1/Beclin1 peptide induced autophagy and protected against IRI. These results suggest the dependence of IPC protection on renal autophagy. During IPC, the mitophagy regulator PINK1 (PTEN induced putative kinase 1) was activated. Both IPC and BECN1 peptide enhanced mitolysosome formation during renal IRI in mitophagy reporter mice, suggesting that IPC may protect kidneys by activating mitophagy. We further established an in vitro model of IPC by inducing 'chemical ischemia' in kidney proximal tubular cells with carbonyl cyanide 3-chlorophenylhydrazone (CCCP). Brief treatment with CCCP protected against subsequent injury in these cells and the protective effect was abrogated by autophagy inhibition. In vitro IPC increased mitophagosome formation, enhanced the delivery of mitophagosomes to lysosomes, and promoted the clearance of damaged mitochondria during subsequent CCCP treatment. IPC also suppressed mitochondrial depolarization, improved ATP production, and inhibited the generation of reactive oxygen species. Knockdown of Pink1 suppressed mitophagy and reduced the cytoprotective effect of IPC. Together, these results suggest that autophagy, especially mitophagy, plays an important role in the protective effect of IPC.Abbreviations: ACTB: actin, beta; ATG: autophagy related; BNIP3: BCL2 interacting protein 3; BNIP3L/NIX: BCL2 interacting protein 3 like; BUN: blood urea nitrogen; CASP3: caspase 3; CCCP: carbonyl cyanide 3-chlorophenylhydrazone; COX4I1: cytochrome c oxidase subunit 4I1; COX8: cytochrome c oxidase subunit 8; DAPI: 4',6-diamidino-2-phenylindole; DNM1L: dynamin 1 like; EGFP: enhanced green fluorescent protein; EM: electron microscopy; ER: endoplasmic reticulum; FC: floxed control; FIS1: fission, mitochondrial 1; FUNDC1: FUN14 domain containing 1; H-E: hematoxylin-eosin; HIF1A: hypoxia inducible factor 1 subunit alpha; HSPD1: heat shock protein family D (Hsp60) member 1; IMMT/MIC60: inner membrane mitochondrial protein; IPC: ischemic preconditioning; I-R: ischemia-reperfusion; IRI: ischemia-reperfusion injury; JC-1: 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide; KO: knockout; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; mito-QC: mito-quality control; mRFP: monomeric red fluorescent protein; NAC: N-acetylcysteine; PINK1: PTEN induced putative kinase 1; PPIB: peptidylprolyl isomerase B; PRKN: parkin RBR E3 ubiquitin protein ligase; ROS: reactive oxygen species; RPTC: rat proximal tubular cells; SD: standard deviation; sIPC: simulated IPC; SQSTM1/p62: sequestosome 1; TOMM20: translocase of outer mitochondrial membrane 20; TUNEL: terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling.
32 citations
••
TL;DR: To the Editor: A 2007 American Heart Association panel concluded that there remains a lack of data on the outcomes of percutaneous coronary intervention after ST-segment elevation myocardial infarction in very elderly patients.
32 citations
••
TL;DR: Results suggest potential for anti-Abeta and anti-RAGE IgGs as blood biomarkers for AD and they are associated with a profile of deficiency in domains associated with specific cortical function.
Abstract: GE distributions have shifted toward a more aged pop-ulation ( 1 , 2 ), and planning for resultant changes in health-related needs requires signifi cant attention. The lead-ing causes of death in industrialized nations have changed over the past century from infectious to chronic diseases ( 3 ). Among major age-related diseases, such as athero sclerosis, diabetes, cancer, and Alzheimer’s disease (AD), the main factor contributing to disease pathology is immune chronic infl ammation ( 4 ). This study assesses the role of the immune system in dementing illness with particular attention to AD. AD is a neurodegenerative disease marked by increasing deterioration of brain tissue, concentrated in the neocortex and hippocampus. Core symptoms include defi cits in mem-ory and cognition. The pathology of AD is complicated, but several abnormalities of structure and function in the brain are hallmarks of the disease. The acetylcholine (ACh) neu-rotransmitter system — involved in cognition and memory — is underproductive in the AD brain. Primary treatments for the disease, acetylcholinesterase (AChE) inhibitors, work to revitalize cholinergic functioning by blocking the activity of AchE, which normally breaks down ACh ( 5 ). Lack of function in this system is probably due to physical degen-eration of neuronal cell tissue, a process resulting in ven-tricular enlargement, development of neurofi brillary tangles, and accumulation of extracellular amyloid plaques. Research supports a central role for amyloid-beta (A b ) proteins in these plaques. A b protein is composed of 40 – 42 amino acid peptides in the amyloid protein family; is known for having a high beta-sheet secondary structure making it resistant to degradation; and is associated with a tendency to aggregate (for review see 6). Although A b formation was once viewed as the major contributor to neuronal death in AD, this theory has been challenged ( 7 ). Recent studies sup-port a complex etiology of AD, with interactions among many types of molecules in the AD brain and periphery ( 8 , 9 , 10 ).
32 citations
••
TL;DR: New insights are provided into the molecular mechanisms underlying diabetic tubulointerstitial injury as well as potential targets for diagnosis and therapeutics of DN.
Abstract: Diabetic nephropathy (DN) is a primary cause of renal failure. However, studies providing renal gene expression profiles of diabetic tubulointerstitial injury are scarce and its molecular mechanisms still await clarification. To identify vital genes involved in the diabetic tubulointerstitial injury, three microarray data sets from gene expression omnibus (GEO) were downloaded. A total of 127 differentially expressed genes (DEGs) were identified by limma package. Gene set enrichment analysis (GSEA) plots showed that sister chromatid cohesion was the most significant enriched gene set positively correlated with the DN group while retinoid X receptor binding was the most significant enriched gene set positively correlated with the control group. Enriched Gene Ontology (GO) annotations and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of DEGs mostly included extracellular matrix organization, extracellular space, extracellular matrix structural constituent, and Staphylococcus aureus infection. Twenty hub genes from three significant modules were ascertained by Cytoscape. Correlation analysis and subgroup analysis between hub genes and clinical features of DN showed that ALB, ANXA1, APOH, C3, CCL19, COL1A2, COL3A1, COL4A1, COL6A3, CXCL6, DCN, EGF, HRG, KNG1, LUM, SERPINA3, SPARC, SRGN, and TIMP1 may involve in diabetic tubulointerstitial injury. ConnectivityMap analysis indicated the most significant three compounds are 5182598, thapsigargin and 5224221. In conclusion, this study may provide new insights into the molecular mechanisms underlying diabetic tubulointerstitial injury as well as potential targets for diagnosis and therapeutics of DN.
32 citations
••
TL;DR: It is demonstrated that mice immunized with N-agrin showed MG-associated symptoms including muscle weakness, fragmented and distorted NMJs, and observations suggest that agrin antibodies may be play a role in MG pathogenesis.
31 citations
Authors
Showing all 353 results
Name | H-index | Papers | Citations |
---|---|---|---|
Zheng Dong | 70 | 283 | 24123 |
Lin Mei | 69 | 245 | 15903 |
Wen Cheng Xiong | 64 | 194 | 12171 |
Ruth B. Caldwell | 60 | 214 | 12314 |
Darrell W. Brann | 60 | 188 | 11066 |
Steven S. Coughlin | 56 | 303 | 12401 |
Martha K. Terris | 55 | 375 | 12346 |
Susan C. Fagan | 53 | 179 | 10135 |
Adviye Ergul | 48 | 188 | 7678 |
Kebin Liu | 46 | 128 | 7271 |
Maribeth H. Johnson | 45 | 125 | 5189 |
Azza B. El-Remessy | 44 | 123 | 5746 |
Yutao Liu | 43 | 152 | 5657 |
William D. Hill | 41 | 101 | 9870 |
Yuqing Huo | 41 | 114 | 9815 |